What is Fertilis?
Fertilis is at the forefront of revolutionizing IVF procedures with its proprietary technology. The company develops an automated IVF system where each embryo is nurtured within its own unique, patented micro-3D printed pod. This advanced pod design not only safeguards the embryo but also facilitates automated, subtle adjustments to the surrounding nutritive solutions, optimizing growth conditions. Based in Adelaide, South Australia, Fertilis aims to enhance the efficiency and success rates of IVF treatments through technological innovation.
How much funding has Fertilis raised?
Fertilis has raised a total of $2.5M across 1 funding round:
Angel/Seed
$2.5M
Angel/Seed (2022): $2.5M with participation from Horizons Ventures
Key Investors in Fertilis
Horizons Ventures
Horizons Ventures is a prominent investment firm that focuses on deep science and technology initiatives aimed at advancing humanity. They support innovative projects with transformative potential, particularly in the science and technology sectors, seeking to foster advancements for a better world.
What's next for Fertilis?
With the recent major strategic investment, Fertilis is poised for significant expansion and further development of its automated IVF technology. The substantial capital infusion is expected to accelerate the commercialization of its patented micro-3D printed pod system, potentially scaling its operations to meet growing global demand. This funding will likely support enhanced research and development, regulatory approvals, and market penetration strategies, positioning Fertilis as a key player in the reproductive health technology sector.
See full Fertilis company page
